These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27194019)

  • 21. Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakagawa N; Muto T; Sasaki H; Urabe K; Sueda T
    J Gastrointest Surg; 2013 Aug; 17(8):1429-39. PubMed ID: 23797881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma.
    Gürlevik E; Fleischmann-Mundt B; Armbrecht N; Longerich T; Woller N; Kloos A; Hoffmann D; Schambach A; Wirth TC; Manns MP; Zender L; Kubicka S; Kühnel F
    Hepatology; 2013 Sep; 58(3):1031-41. PubMed ID: 23686746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy.
    Toyota K; Murakami Y; Kondo N; Uemura K; Nakagawa N; Takahashi S; Sueda T
    Ann Surg Oncol; 2018 May; 25(5):1202-1210. PubMed ID: 29492748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Strategy of Treatment for Mid to Distal Cholangiocarcinoma after Surgical Resection.
    Lee SR; Kim HO; Shin JH
    Am Surg; 2018 Jun; 84(6):820-825. PubMed ID: 29981608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
    Loveday BPT; Knox JJ; Dawson LA; Metser U; Brade A; Horgan AM; Gallinger S; Greig PD; Moulton CA
    J Surg Oncol; 2018 Feb; 117(2):213-219. PubMed ID: 29480952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.
    Mao K; Liu J; Sun J; Zhang J; Chen J; Pawlik TM; Jacobs LK; Xiao Z; Wang J
    J Gastroenterol Hepatol; 2016 Feb; 31(2):417-26. PubMed ID: 26250532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer.
    Ebata T; Hirano S; Konishi M; Uesaka K; Tsuchiya Y; Ohtsuka M; Kaneoka Y; Yamamoto M; Ambo Y; Shimizu Y; Ozawa F; Fukutomi A; Ando M; Nimura Y; Nagino M;
    Br J Surg; 2018 Feb; 105(3):192-202. PubMed ID: 29405274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection.
    Kobayashi H; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Sueda T
    Ann Surg; 2012 Aug; 256(2):288-96. PubMed ID: 22580938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma.
    Morine Y; Shimada M; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Imura S
    Anticancer Res; 2017 Nov; 37(11):6421-6428. PubMed ID: 29061828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Reames BN; Bagante F; Ejaz A; Spolverato G; Ruzzenente A; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    HPB (Oxford); 2017 Oct; 19(10):901-909. PubMed ID: 28728891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Survival after resection for perihilar cholangiocarcinoma: Impact of UICC staging and surgical procedure.
    Juntermanns B; Kaiser GM; Reis H; Gries S; Kasper S; Paul A; Canbay A; Fingas CD
    Turk J Gastroenterol; 2019 May; 30(5):454-460. PubMed ID: 31061000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of treatment methods and prognostic factors in 354 cases of hilar cholangiocarcinoma: A cohort study.
    Sun Z; Feng Y; Liu H; Shen F; Xiao J; Kang X; Zhao Y; Xiao H; Zhao W; Hu X; Li J; Ma H; Cao G; Su N; Zhang B
    J Cancer Res Ther; 2020; 16(2):230-237. PubMed ID: 32474506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant surgery for advanced extrahepatic cholangiocarcinoma.
    Oshiro Y; Takahashi K; Sasaki R; Kondo T; Sakashita S; Ohkohchi N
    World J Gastroenterol; 2013 Oct; 19(40):6934-8. PubMed ID: 24187473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.